Wahida Rahaman-Dwarika, FNP

Wahida Rahaman-Dwarika practices at TGH Imaging Wesley Chapel in Wesley Chapel, Florida.

Wahida Rahaman-Dwarika's NPI, 1023633104, was assigned on June 14, 2020. Wahida Rahaman-Dwarika holds Florida license APRN11006378.

Wahida Rahaman-Dwarika's primary practice is TGH Imaging Wesley Chapel, at 2324 Oak Myrtle Ln, Wesley Chapel, FL 33544. The practice phone is (813) 874-3177.

Wahida Rahaman-Dwarika's primary practice is TGH Imaging Wesley Chapel in Wesley Chapel, Florida. Wahida Rahaman-Dwarika is also affiliated with Tampa General Hospital. The medical group on file is Tampa General Medical Group (TGMG). Wahida Rahaman-Dwarika's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Wahida Rahaman-Dwarika practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Wahida Rahaman-Dwarika's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Wahida Rahaman-Dwarika is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, arthritis, chronic diabetes, cold sores or genital herpes, conjunctivitis and contact dermatitis among the conditions Wahida Rahaman-Dwarika treats.

CMS data shows 149 Medicare services from Wahida Rahaman-Dwarika across 2 procedure codes in 2024, all of them office visits, for 139 Medicare patients. Medicare paid $8,915 for them. Every service was in an office.

CMS counts 139 Medicare patients who saw Wahida Rahaman-Dwarika in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Wahida Rahaman-Dwarika's median patient age at 53, with 69% women.

In 2024, Wahida Rahaman-Dwarika wrote 1,072 Medicare Part D claims for 241 patients. 84% of them were for generic drugs. CMS names the drug for 611 of them, across 26 drugs with 11 or more claims each, at $50,859 in total drug cost.

Wahida Rahaman-Dwarika accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Wahida Rahaman-Dwarika as offering telehealth.

CMS Open Payments shows 5 general payments to Wahida Rahaman-Dwarika from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $102.